• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常和恶性人类甲状腺组织中分化及去分化标志物的基因表达

Gene expression of differentiation- and dedifferentiation markers in normal and malignant human thyroid tissues.

作者信息

Hoang-Vu C, Dralle H, Scheumann G, Maenhaut C, Horn R, von zur Mühlen A, Brabant G

机构信息

Department of Clinical Endocrinology, Medical School of Hannover, Germany.

出版信息

Exp Clin Endocrinol. 1992;100(1-2):51-6. doi: 10.1055/s-0029-1211176.

DOI:10.1055/s-0029-1211176
PMID:1281780
Abstract

Steady state mRNA transcript levels of thyroid differentiation markers such as TSH receptor (TSHR), thyroglobulin (Tg) and thyroid peroxidase (TPO) as well as a potential marker of dedifferentiation, c-myc, marker were investigated in patients with thyroid tumors and in normal controls using Northern blot analysis. Blots were normalized by acridine orange staining whereas analysis of beta-actin mRNA levels revealed highly variable levels already in normal tissue suggesting regulation of this "constitutively" expressed gene. Determination of c-myc mRNA revealed increased steady state mRNA levels in anaplastic carcinomas (ATC) as compared to normal tissues. However, in some patients c-myc transcript levels were lower in the tumor than in the adjacent normal tissue reducing the significance of c-myc as a marker of dedifferentiation. High levels of TSH mRNA were found in control thyroids, whereas in ATC no normal TSHR mRNA was detected. In PTC and follicular thyroid carcinomas (FTC) the transcripts varied from increased to markedly reduced levels. In one patient with FTC 2 independent preparations of the tumor revealed different results, undetectable and clearly detectable TSHR mRNA levels. Xenotransplantation of this tissue on nude rats showed a variable expression pattern in the individual xenotransplantations suggesting heterogeneity of the tumor tissue. Tg and TPO mRNA were strongly expressed in normal tissues and completely lost in all ATC. In differentiated thyroid tumors the transcript levels of Tg and TPO varied from normal to complete loss of expression of either Tg or TPO, or both.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

采用Northern印迹分析法,对甲状腺肿瘤患者和正常对照者中甲状腺分化标志物(如促甲状腺激素受体(TSHR)、甲状腺球蛋白(Tg)和甲状腺过氧化物酶(TPO))以及去分化潜在标志物c-myc的稳态mRNA转录水平进行了研究。印迹通过吖啶橙染色进行标准化,而β-肌动蛋白mRNA水平分析显示,正常组织中该水平已经高度可变,提示该“组成性”表达基因存在调控。c-myc mRNA的测定显示,与正常组织相比,间变性癌(ATC)中的稳态mRNA水平升高。然而,在一些患者中,肿瘤组织中的c-myc转录水平低于相邻正常组织,这降低了c-myc作为去分化标志物的意义。在对照甲状腺中发现高水平的TSH mRNA,而在ATC中未检测到正常的TSHR mRNA。在乳头状甲状腺癌(PTC)和滤泡状甲状腺癌(FTC)中,转录水平从升高到明显降低不等。在1例FTC患者中,肿瘤的2份独立标本显示出不同结果,TSHR mRNA水平分别为不可检测和明显可检测。将该组织异种移植到裸鼠上,在个体异种移植中显示出可变的表达模式,提示肿瘤组织具有异质性。Tg和TPO mRNA在正常组织中强烈表达,在所有ATC中完全缺失。在分化型甲状腺肿瘤中,Tg和TPO的转录水平从正常到Tg或TPO或两者表达完全缺失不等。(摘要截短至250字)

相似文献

1
Gene expression of differentiation- and dedifferentiation markers in normal and malignant human thyroid tissues.正常和恶性人类甲状腺组织中分化及去分化标志物的基因表达
Exp Clin Endocrinol. 1992;100(1-2):51-6. doi: 10.1055/s-0029-1211176.
2
Human thyrotropin receptor gene: expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation.人类促甲状腺激素受体基因:在甲状腺肿瘤中的表达及其与甲状腺分化和去分化标志物的相关性
Mol Cell Endocrinol. 1991 Nov;82(1):R7-12. doi: 10.1016/0303-7207(91)90018-n.
3
Expression of thyrotropin receptor (TSH-R), thyroglobulin, thyroperoxidase, and calcitonin messenger ribonucleic acids in thyroid carcinomas: evidence of TSH-R gene transcript in medullary histotype.甲状腺癌中促甲状腺激素受体(TSH-R)、甲状腺球蛋白、甲状腺过氧化物酶及降钙素信使核糖核酸的表达:髓样组织学类型中TSH-R基因转录本的证据
J Clin Endocrinol Metab. 1994 Apr;78(4):867-71. doi: 10.1210/jcem.78.4.8157713.
4
Immunohistochemical loss of thyroid peroxidase in papillary thyroid carcinoma: strong suppression of peroxidase gene expression.甲状腺乳头状癌中甲状腺过氧化物酶的免疫组化缺失:过氧化物酶基因表达的强烈抑制
J Pathol. 1996 May;179(1):89-94. doi: 10.1002/(SICI)1096-9896(199605)179:1<89::AID-PATH546>3.0.CO;2-R.
5
The mRNA levels of thyrotropin receptor, thyroglobulin and thyroid peroxidase in neoplastic human thyroid tissues.人甲状腺肿瘤组织中促甲状腺激素受体、甲状腺球蛋白和甲状腺过氧化物酶的mRNA水平。
Biochem Biophys Res Commun. 1991 Feb 14;174(3):1148-53. doi: 10.1016/0006-291x(91)91540-s.
6
Dedifferentiation of differentiated thyroid carcinoma cell line FTC-133 is enhanced by 131I pretreatment.分化型甲状腺癌细胞系 FTC-133 的去分化可被 131I 预处理增强。
Nucl Med Biol. 2011 Oct;38(7):1053-8. doi: 10.1016/j.nucmedbio.2011.03.001. Epub 2011 Apr 21.
7
Expression of iodine metabolism genes in human thyroid tissues: evidence for age and BRAFV600E mutation dependency.人甲状腺组织中碘代谢基因的表达:年龄和BRAFV600E突变依赖性的证据。
Clin Endocrinol (Oxf). 2009 Apr;70(4):629-35. doi: 10.1111/j.1365-2265.2008.03376.x. Epub 2008 Aug 15.
8
[Gene expression of thyrotropin receptor, thyroid peroxidase and thyroglobulin in autoimmune thyroid disease].[自身免疫性甲状腺疾病中促甲状腺激素受体、甲状腺过氧化物酶和甲状腺球蛋白的基因表达]
Zhonghua Nei Ke Za Zhi. 1997 Oct;36(10):685-8.
9
TSH-receptor expression and human thyroid disease: relation to clinical, endocrine, and molecular thyroid parameters.促甲状腺激素受体表达与人类甲状腺疾病:与临床、内分泌及分子甲状腺参数的关系
Thyroid. 1996 Dec;6(6):575-87. doi: 10.1089/thy.1996.6.575.
10
E-cadherin: a differentiation marker in thyroid malignancies.E-钙黏蛋白:甲状腺恶性肿瘤中的一种分化标志物。
Cancer Res. 1993 Oct 15;53(20):4987-93.

引用本文的文献

1
Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation.甲状腺癌中的基因改变介导对BRAF抑制的抗性和间变性转化。
Oncotarget. 2024 Jan 24;15:36-48. doi: 10.18632/oncotarget.28544.
2
A Review of Evidence for the Involvement of the Circadian Clock Genes into Malignant Transformation of Thyroid Tissue.生物钟基因参与甲状腺组织恶性转化的证据综述
Clocks Sleep. 2023 Jul 13;5(3):384-398. doi: 10.3390/clockssleep5030029.
3
Prospects of Testing Diurnal Profiles of Expressions of TSH-R and Circadian Clock Genes in Thyrocytes for Identification of Preoperative Biomarkers for Thyroid Carcinoma.
检测甲状腺细胞中 TSH-R 和昼夜节律基因表达的日间谱以鉴定甲状腺癌术前生物标志物的前景。
Int J Mol Sci. 2022 Oct 13;23(20):12208. doi: 10.3390/ijms232012208.
4
Immunotherapy for advanced thyroid cancers - rationale, current advances and future strategies.晚期甲状腺癌的免疫治疗——原理、当前进展和未来策略。
Nat Rev Endocrinol. 2020 Nov;16(11):629-641. doi: 10.1038/s41574-020-0398-9. Epub 2020 Aug 24.
5
Circulating thyroid stimulating hormone receptor messenger RNA and differentiated thyroid cancer: A diagnostic meta-analysis.循环甲状腺刺激激素受体信使核糖核酸与分化型甲状腺癌:一项诊断性荟萃分析。
Oncotarget. 2017 Jan 24;8(4):6623-6629. doi: 10.18632/oncotarget.14251.
6
Establishment and characterization of novel human primary and metastatic anaplastic thyroid cancer cell lines and their genomic evolution over a year as a primagraft.新型人原发性和转移性间变性甲状腺癌细胞系的建立与鉴定及其作为原代移植瘤在一年中的基因组进化
J Clin Endocrinol Metab. 2015 Feb;100(2):725-35. doi: 10.1210/jc.2014-2359. Epub 2014 Nov 3.
7
The H723R mutation in the PDS/SLC26A4 gene is associated with typical Pendred syndrome in Korean patients.PDS/SLC26A4基因中的H723R突变与韩国患者的典型彭德莱综合征相关。
Endocrine. 2006 Oct;30(2):237-43. doi: 10.1385/ENDO:30:2:237.
8
Thyroid peroxidase immunohistochemistry in differential diagnosis of thyroid tumors.
Endocr Pathol. 2006 Spring;17(1):53-60. doi: 10.1385/ep:17:1:53.
9
Expression of pendrin in benign and malignant human thyroid tissues.
Br J Cancer. 2005 Jul 11;93(1):144-51. doi: 10.1038/sj.bjc.6602628.
10
Evidence for transcriptional and posttranscriptional alterations of the sodium/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors.甲状腺功能减退的良性和恶性甲状腺肿瘤中钠/碘同向转运体表达的转录和转录后改变的证据。
Am J Pathol. 2004 Jul;165(1):25-34. doi: 10.1016/S0002-9440(10)63272-5.